INVERNIZZI, SABRINA
INVERNIZZI, SABRINA
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons
2023 S. Invernizzi, S. Santangelo, E. Bussani, G. Romano, C. Colombrita, V. Casiraghi, M. Nice Sorce, P. Bossolasco, V. Silani, F. Pagani, A. Ratti
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis
2023 A. Manini, V. Casiraghi, A. Brusati, A. Maranzano, F. Gentile, E. Colombo, R. Bonetti, S. Peverelli, S. Invernizzi, D. Gentilini, S. Messina, F. Verde, B. Poletti, I. Fogh, C. Morelli, V. Silani, A. Ratti, N. Ticozzi
Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study
2023 A. Brusati, S. Peverelli, L. Calzari, C. Tiloca, V. Casiraghi, M.N. Sorce, S. Invernizzi, E. Carbone, R. Cavagnola, F. Verde, V. Silani, N. Ticozzi, A. Ratti, D. Gentilini
Human motor neurons derived from induced pluripotent stem cells are susceptible to SARS-CoV-2 infection
2023 G. Cappelletti, C. Colombrita, F. Limanaqi, S. Invernizzi, M. Garziano, C. Vanetti, C. Moscheni, S. Santangelo, S. Zecchini, D. Trabattoni, V. Silani, M. Clerici, A. Ratti, M. Biasin
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy
2023 V. Casiraghi, C. Colombrita, S. Santangelo, S. Invernizzi, M.N. Sorce, P. Bossolasco, V. Silani, A. Ratti
Generation of an iPSC line from a patient with spastic paraplegia type 10 carrying a novel mutation in KIF5A gene
2023 S. Santangelo, P. Bossolasco, S. Magri, C. Colombrita, S. Invernizzi, C. Gellera, L. Nanetti, D. Di Bella, V. Silani, F. Taroni, A. Ratti
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons
2022 S. Santangelo, C. Colombrita, E. Bussani, S. Invernizzi, M. Nice Sorce, V. Casiraghi, C. Lattuada, P. Bossolasco, V. Silani, F. Pagani, A. Ratti
Characterization of iPSC-motoneurons from a HSP patient with a novel mutation in KIF5A N-terminal region Characterization of iPSCmotoneurons from a HSP patient with a novel mutation in KIF5A N-terminal region
2022 S. Santangelo, P. Bossolasco, C. Fallini, S. Magri, M. Bertocchi, S. Invernizzi, D. Di Bella, D. Bardelli, C. Colombrita, V. Silani, F. Taroni, A. Ratti
Modeling a novel N-terminal mutation of KIF5A gene in patient-derived iPSC-motoneurons
2022 S. Santangelo, P. Bossolasco, C. Fallini, S. Magri, M. Bertocchi, S. Invernizzi, D. Di Bella, D. Bardelli, C. Colombrita, V. Silani, F. Taroni, A. Ratti
Human in vitro models of TDP-43 proteinopathy for drug screening approaches
2022 V. Casiraghi, C. Colombrita, S. Santangelo, S. Invernizzi, M.N. Sorce, V. Silani, A. Ratti
Effect of NEK1/C9ORF72 double mutation on DNA damage response in patient-derived neural stem cells
2021 S. Santangelo, C. Colombrita, P. Bossolasco, S. Peverelli, S. Invernizzi, A. Brusati, V. Gumina, D. Bardelli, N. Ticozzi, V. Silani, A. Ratti
Effect of NEK1/C9ORF72 double mutation on DNA damage response in neural stem cells and motoneurons derived from Amyotrophic Lateral Sclerosis patient
2021 S. Santangelo, C. Colombrita, P. Bossolasco, S. Peverelli, S. Invernizzi, A. Brusati, V. Gumina, D. Bardelli, N. Ticozzi, V. Silani, A. Ratti
Effect of the C9ORF72-NEK1 double mutation on DNA damage response in patient-derived iPSC-motoneurons
2021 S. Santangelo, C. Colombrita, P. Bossolasco, S. Peverelli, S. Invernizzi, A. Brusati, V. Gumina, D. Bardelli, N. Ticozzi, V. Silani, A. Ratti